Companies / Materials
MOS
Mosaic Company (The)
Fertilizers & Agricultural Chemicals
Fertilizers & Agricultural ChemicalsAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health32
Growth31
Profitability26
Cash generation1
Balance sheet20
Dilution control82
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)-10.2%Revenue growth (FY)8.4%Revenue CAGR (3y)-14.3%Gross margin15.8%Operating margin6.8%Net margin4.5%Free cash flow margin-4.4%R&D / revenue—Stock comp / revenue0.3%Net debt / operating cash flow5.74xCurrent ratio1.32Diluted share count change-0.6%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $12.4B | $19.1B | $13.7B | $11.1B | $12.1B |
| Gross profit | $3.2B | $5.8B | $2.2B | $1.5B | $1.9B |
| Operating income | $2.5B | $4.8B | $1.3B | $622M | $822M |
| Net income | $1.6B | $3.6B | $1.2B | $175M | $541M |
| Operating cash flow | $2.2B | $3.9B | $2.4B | $1.3B | $825M |
| Capital expenditure | $1.3B | $1.2B | $1.4B | $1.3B | $1.4B |
| Free cash flow | $898M | $2.7B | $1.0B | $47M | -$535M |
| Stock-based comp | $30M | $28M | $33M | $32M | $31M |
| Buybacks | $411M | $1.7B | $756M | $235M | $0 |
| Dividends | $104M | $198M | $352M | $271M | $280M |
| Cash | $770M | $735M | $349M | $273M | $277M |
| Total debt | $3.7B | $2.6B | $3.6B | $4.2B | $5.0B |
| Equity | $10.6B | $12.1B | $12.3B | $11.5B | $12.1B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.